← Back to Healthcare

Biotechnology

Industry Overview

Stock Screener

Select filters to narrow down the 74 companies below

74 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

ARCA biopharma Inc

ABIO

ARCA biopharma Inc

ABIO
Market Cap $6.51B
Dividends 0.0%
P/E Ratio -43.7
Revenue $0.00
Net Income -$41.2M +67.7%
Profit Margin
Employees 28
View Stock

Oruka Therapeutics, Inc.

ORKA

Oruka Therapeutics, Inc.

ORKA
Market Cap $6.51B
Dividends 0.0%
P/E Ratio -43.7
Revenue $0.00
Net Income -$41.2M +67.7%
Profit Margin
Employees 28
View Stock

Mind Medicine Inc

MNMD

Mind Medicine Inc

MNMD
Market Cap $5.96B
Dividends 0.0%
P/E Ratio -13.1
Revenue $0.00
Net Income -$159M +271.9%
Profit Margin
Employees 74
View Stock

Definium Therapeutics, Inc.

DFTX

Definium Therapeutics, Inc.

DFTX
Market Cap $5.96B
Dividends 0.0%
P/E Ratio -13.1
Revenue $0.00
Net Income -$159M +271.9%
Profit Margin
Employees 74
View Stock

Parabilis Medicines, Inc.

PBLS

Parabilis Medicines, Inc.

PBLS
Market Cap $4.59B
Dividends 0.0%
P/E Ratio -1.1
Revenue $148k
Net Income -$52.5M
Profit Margin -35448.0%
Employees 145
View Stock

Veradermics, Incorporated

MANE

Veradermics, Incorporated

MANE
Market Cap $4.3B
Dividends 0.0%
P/E Ratio -48.0
Revenue $0.00
Net Income -$23.5M
Profit Margin
Employees 21
View Stock

MBX Biosciences, Inc. Common Stock

MBX

MBX Biosciences, Inc. Common Stock

MBX
Market Cap $3.16B
Dividends 0.0%
P/E Ratio -27.6
Revenue $0.00
Net Income -$37.1M +91.1%
Profit Margin
Employees 43
View Stock

Alamar Biosciences, Inc.

ALMR

Alamar Biosciences, Inc.

ALMR
Market Cap $2.37B
Dividends 0.0%
P/E Ratio -64.6
Revenue $29.4M
Net Income -$13.2M
Profit Margin -44.9%
Employees 222
View Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Market Cap $2.3B
Dividends 0.0%
P/E Ratio -37.5
Revenue $0.00
Net Income -$24.2M
Profit Margin
Employees 72
View Stock

Kailera Therapeutics, Inc.

KLRA

Kailera Therapeutics, Inc.

KLRA
Market Cap $2.22B
Dividends 0.0%
P/E Ratio -9.8
Revenue $0.00
Net Income -$111M
Profit Margin
Employees 145
View Stock

Zenas BioPharma, Inc.

ZBIO

Zenas BioPharma, Inc.

ZBIO
Market Cap $2.04B
Dividends 0.0%
P/E Ratio -3.4
Revenue $1M
Net Income -$111M +113.6%
Profit Margin -11145.6%
Employees 130
View Stock

Pieris Pharmaceuticals Inc

PIRS

Pieris Pharmaceuticals Inc

PIRS
Market Cap $2.04B
Dividends 0.0%
P/E Ratio -2.8
Revenue $0.00
Net Income -$21.9M +130.9%
Profit Margin
Employees 14
View Stock

Palvella Therapeutics, Inc.

PVLA

Palvella Therapeutics, Inc.

PVLA
Market Cap $2.04B
Dividends 0.0%
P/E Ratio -29.4
Revenue $0.00
Net Income -$21.9M +130.9%
Profit Margin
Employees 14
View Stock

Kardigan, Inc.

KARD

Kardigan, Inc.

KARD
Market Cap $1.88B
Dividends 0.0%
P/E Ratio -9.8
Revenue $0.00
Net Income -$116M
Profit Margin
Employees 241
View Stock

Septerna, Inc.

SEPN

Septerna, Inc.

SEPN
Market Cap $1.8B
Dividends 0.0%
P/E Ratio -74.1
Revenue $26.7M +22375.6%
Net Income -$13M -47.5%
Profit Margin -48.7%
Employees 75
View Stock

Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

AVLN
Market Cap $1.7B
Dividends 0.0%
P/E Ratio -29.7
Revenue $0.00
Net Income -$28.9M
Profit Margin
Employees 50
View Stock

Bicara Therapeutics Inc. Common Stock

BCAX

Bicara Therapeutics Inc. Common Stock

BCAX
Market Cap $1.57B
Dividends 0.0%
P/E Ratio -7.7
Revenue $0.00
Net Income -$55.4M +102.4%
Profit Margin
Employees 55
View Stock

LB Pharmaceuticals Inc Common Stock

LBRX

LB Pharmaceuticals Inc Common Stock

LBRX
Market Cap $1.37B
Dividends 0.0%
P/E Ratio -16.0
Revenue $0.00
Net Income -$51.6M
Profit Margin
Employees 16
View Stock

Seaport Therapeutics, Inc. Common Stock

SPTX

Seaport Therapeutics, Inc. Common Stock

SPTX
Market Cap $1.3B
Dividends 0.0%
P/E Ratio -14.7
Revenue $0.00
Net Income -$62.6M
Profit Margin
Employees 54
View Stock

Aerovate Therapeutics Inc

AVTE

Aerovate Therapeutics Inc

AVTE
Market Cap $1.3B
Dividends 0.0%
P/E Ratio -7.8
Revenue $0.00
Net Income -$55.8M +73.5%
Profit Margin
Employees 50
View Stock